Blueprint Medicines Corporation
Clinical trials sponsored by Blueprint Medicines Corporation, explained in plain language.
-
New hope for kids with Tough-to-Treat cancers
Disease control CompletedThis study tested a drug called avapritinib in children and teenagers (ages 2 to 18) with advanced solid tumors, including brain tumors, that had come back or stopped responding to standard treatments. The trial aimed to find a safe dose and see if the drug could shrink tumors in…
Phase: PHASE1, PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New allergy pill shows promise in early testing
Disease control CompletedThis study tested an experimental pill called BLU-808 for people with ragweed allergies. Researchers checked if the drug was safe, how it moved through the body, and if it helped reduce allergy symptoms like sneezing and itchy eyes. Participants were exposed to ragweed pollen in …
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC